ArticleTherapeutic advances in musculoskeletal disease2025

Tofacitinib in early active axial spondyloarthritis: protocol of a randomized double-blind, placebo-controlled, multicenter phase IV study, FASTLANE.

Valeria Rios Rodriguez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.